Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 13.29M P/E 1.67 EPS this Y - Ern Qtrly Grth -
Income -44.24M Forward P/E -2.33 EPS next Y - 50D Avg Chg 13.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -1.00%
Dividend N/A Price/Book N/A EPS next 5Y -23.33% 52W High Chg -83.00%
Recommedations 3.00 Quick Ratio 1.92 Shares Outstanding 37.98M 52W Low Chg 84.00%
Insider Own 27.73% ROA -41.29% Shares Float 1.83M Beta 1.29
Inst Own 8.75% ROE -269.01% Shares Shorted/Prior 34.05K/103.01K Price 0.35
Gross Margin - Profit Margin - Avg. Volume 555,517 Target Price -
Oper. Margin - Earnings Date Mar 28 Volume 150,303 Change -5.15%
About Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California.

CBIO Chatroom

User Image CocaKolla Posted - 04/05/24

$CBIO 😎😎

User Image CocaKolla Posted - 04/05/24

$CBIO 💪💪

User Image CocaKolla Posted - 04/05/24

$CBIO still HOLDING 💪💪

User Image TradingUK Posted - 03/04/24

$CRDF Hold long term and you will see gains like $AMAM $CBIO 🍀

User Image _StockTrader Posted - 2 months ago

Real-Time Stock Data $CBIO Price: N/A Volume: N/A Market Cap: N/A PE Ratio: N/A Stock data provided by: AITX

User Image _StockTrader Posted - 02/23/24

Real-Time Stock Data $CBIO Price: N/A Volume: N/A Market Cap: N/A PE Ratio: N/A Stock data provided by: AITX

User Image advicegiver Posted - 02/16/24

$bzun finally broke out of 2.50 area. Strong move next week when China market opens. Get in now!! $cbio $bspm $bili $sgmo

User Image Krackalacka Posted - 01/04/24

@tradethehalt you missed $GYRE 1-15 split from $CBIO

User Image tickeron Posted - 12/24/23

If you have $APVO or $CBIO in your portfolio, pay attention! #AptevoTherapeutics https://srnk.us/go/4950247

User Image Chuckyb123 Posted - 12/22/23

$XTIA all I’ve been doing is losing money for 3 yrs. Lol I’m still trying! I just blew it with $CBIO. I’m not doing the same here… got thousands of shares and hoping for a big jump after merger.

User Image Chuckyb123 Posted - 12/22/23

@Garymoved @TheDipMaster not all die. The ones that do a merger tend to bubble. See here $GYRE $CBIO

User Image Chuckyb123 Posted - 12/16/23

$XTIA I would believe you if I wasn’t a part of the people that jumped ship here $CBIO $GYRE when they did a rs merger.

User Image The_Titan_Traders Posted - 12/15/23

$CBIO this stock went up like 5,000% on merger. This $XTIA has the same type of potential. Just look at the news given. Nothing else is needed. 7B dollar merger. 😳😳😳😳😳

User Image Krackalacka Posted - 12/15/23

$CBIO $GYRE reported* idiot.

User Image Krackalacka Posted - 12/15/23

$CBIO $GYRE reorted . Idiot.

User Image Stock_Titan Posted - 12/15/23

$GYRE $CBIO Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding https://www.stocktitan.net/news/GYRE/totus-medicines-announces-appointment-of-nassim-usman-ph-d-as-uo9ps5yvxqov.html

User Image Chuckyb123 Posted - 12/14/23

$CBIO will $XTIA do the same?

User Image Chuckyb123 Posted - 12/14/23

$CBIO $INBS will this do the same after a merger rs??

User Image Chuckyb123 Posted - 12/14/23

@Canbullthebear @hann6034 it might… but like $CBIO $GYRE … that could lead to huge gains!!!!

User Image Chuckyb123 Posted - 12/14/23

@Gcorbs look at $CBIO $GYRE. I’m hoping for same here!

User Image Mouthana Posted - 12/08/23

$GDHG after the research I did this should be at least $3 💰💰 $MLGO $LIFW $CBIO $AMC

User Image Aigner_Andreas Posted - 5 months ago

TF SELL $CBIO at 0.5 : 8.59 NanoCap 48% Shp 1.53 S 0.02 N 0.42 RSI 48.17% SRSI 1.75% ADXR 22.61 #stocks #trading #finance #market

User Image ForUS2Retire Posted - 11/28/23

I Find It Curious That Only 2mil Shares Have Traded Since The $CBIO/$GYRE Deal, But Gyre Has Over 76mil Shares. SOOooo, Only 2.6% Of Shares Involved In Entire Month Of November Trading? Yet Stock Price Rose From $5.88 to $25+ What Happens To The Stock Price When $GYRE Starts Trading 5 to 10% Weekly, Or Even DAILY??? Glta Bulls, Watchers, & StockHOLDERS!!!

User Image KayGamez Posted - 11/27/23

$GYRE $MNY $CBIO Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining!!!<<👉 top-stocks-winning-great.profitablestocks.vip/

User Image MarianneAlexander323 Posted - 11/24/23

$GYRE $MNY $CBIO ACCOUNT CHALLENGE UPDATE: Starting Balance: $3,700 Current Balance: $54,873 Goal: $100K by end of Dec Watch out for our next alert!”.””👉 stocks-live-trading-chat.profitablestocks.vip/

User Image b2dddub2 Posted - 11/20/23

$CBIO $2….? 👀💰🍿

User Image Stocktology Posted - 11/17/23

$CBIO the bottom one in particular should make this a multi runner And for a tiny market cap company this we wouldn’t be surprised if this went to $1+ in the near future

User Image Stocktology Posted - 11/17/23

$CBIO this is HUGE news for a tiny market cap

User Image Fullratio Posted - 11/17/23

Healthcare sector stocks with high YoY gross profit growth in Q3 2023: $CBIO $NEOG $NRIX

User Image Hotstockinggal Posted - 11/15/23

@SirGay_LoveRaw I would have if it wasn’t baffling. HEPA should be double current price with this week’s news. But, they are running out of money so they NEED to do a deal like $CBIO / $GYRE just did. Read between the lines.

Analyst Ratings
Raymond James Market Perform Nov 15, 21
Raymond James Outperform Aug 6, 21
Raymond James Outperform Apr 29, 21
Piper Sandler Overweight Feb 10, 21
Raymond James Outperform Feb 4, 21
Oppenheimer Outperform Jan 4, 19
B. Riley FBR Neutral Jun 21, 18
Chardan Capital Buy Feb 9, 18
B. Riley FBR Buy Dec 8, 17
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
USMAN NASSIM President & CEO President & CEO Aug 09 Buy 0.47 3,250 1,528 24,541 08/10/22
Miller Seline E. SVP Finance; Interim.. SVP Finance; Interim CFO & PAO Aug 09 Buy 0.47 3,250 1,528 6,500 08/10/22
Blouse Grant E. Chief Scientific Off.. Chief Scientific Officer Aug 09 Buy 0.47 3,250 1,528 9,417 08/10/22
USMAN NASSIM President & CEO President & CEO Feb 09 Buy 0.46 3,250 1,495 21,291 02/16/22
Miller Seline E. SVP Finance; Interim.. SVP Finance; Interim CFO & PAO Feb 09 Buy 0.46 3,250 1,495 3,250 02/16/22
Blouse Grant E. Chief Scientific Off.. Chief Scientific Officer Feb 09 Buy 0.46 3,250 1,495 6,167 02/16/22